GSVPX
Price
$14.03
Change
-$0.68 (-4.62%)
Updated
Apr 4 closing price
Net Assets
127.83M
VEMPX
Price
$290.94
Change
-$16.04 (-5.23%)
Updated
Apr 4 closing price
Net Assets
110.09B
Ad is loading...

GSVPX vs VEMPX

Header iconGSVPX vs VEMPX Comparison
Open Charts GSVPX vs VEMPXBanner chart's image
Goldman Sachs Small/Mid Cap Value P
Price$14.03
Change-$0.68 (-4.62%)
VolumeN/A
Net Assets127.83M
Vanguard Extended Market Index InstlPlus
Price$290.94
Change-$16.04 (-5.23%)
VolumeN/A
Net Assets110.09B
GSVPX vs VEMPX Comparison Chart
Loading...
View a ticker or compare two or three
VS
GSVPX vs. VEMPX commentary
Apr 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GSVPX is a Hold and VEMPX is a Hold.

Ad is loading...
FUNDAMENTALS
Fundamentals
VEMPX has more cash in the bank: 110B vs. GSVPX (128M). VEMPX pays higher dividends than GSVPX: VEMPX (1.31) vs GSVPX (1.23). GSVPX was incepted earlier than VEMPX: GSVPX (7 years) vs VEMPX (14 years). GSVPX (1.07) is less costly to investors than VEMPX (0.04). GSVPX is a more actively managed with annual turnover of: 67.00 vs. VEMPX (11.00). GSVPX has a lower initial minimum investment than VEMPX: GSVPX (0) vs VEMPX (100000000). VEMPX annual gain was more profitable for investors over the last year : -8.43 vs. GSVPX (-11.73). VEMPX return over 5 years is better than : 89.19 vs. GSVPX (73.88).
GSVPXVEMPXGSVPX / VEMPX
Total Expense Ratio0.840.042,100%
Annual Report Gross Expense Ratio1.070.042,675%
Fund Existence7 years14 years-
Gain YTD-15.431-18.10285%
Front LoadN/AN/A-
Min. Initial Investment0100000000-
Min. Initial Investment IRAN/AN/A-
Net Assets128M110B0%
Annual Yield % from dividends1.231.3194%
Returns for 1 year-11.73-8.43139%
Returns for 3 years-14.03-4.60305%
Returns for 5 years73.8889.1983%
Returns for 10 yearsN/A74.35-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SRL7.94-0.18
-2.22%
Scully Royalty Ltd
AMPH26.61-0.63
-2.31%
Amphastar Pharmaceuticals
ONTO104.44-5.39
-4.91%
Onto Innovation
CEVA21.28-1.27
-5.63%
CEVA
NAYA1.83-0.27
-12.86%
NAYA Biosciences Inc